Kinnate Biopharma Inc. Current Ratio 2021-2023 | KNTE
Kinnate Biopharma Inc. current ratio from 2021 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2023-12-31 | $0.16B | $0.01B | 13.19 |
| 2023-09-30 | $0.17B | $0.02B | 10.80 |
| 2023-06-30 | $0.19B | $0.02B | 11.96 |
| 2023-03-31 | $0.21B | $0.02B | 11.31 |
| 2022-12-31 | $0.23B | $0.02B | 13.45 |
| 2022-09-30 | $0.26B | $0.02B | 17.02 |
| 2022-06-30 | $0.27B | $0.01B | 23.30 |
| 2022-03-31 | $0.28B | $0.01B | 20.15 |
| 2021-12-31 | $0.26B | $0.01B | 20.88 |
| 2021-09-30 | $0.26B | $0.01B | 25.31 |
| 2021-06-30 | $0.26B | $0.01B | 31.09 |
| 2021-03-31 | $0.25B | $0.01B | 32.23 |
| 2020-12-31 | $0.40B | $0.01B | 54.79 |
| 2020-09-30 | $0.00B | 0.00 | |
| 2020-06-30 | $0.00B | 0.00 | |
| 2020-03-31 | $0.00B | 0.00 | |
